Correlation Between BioAffinity Technologies, and Agilent Technologies
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and Agilent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and Agilent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies, and Agilent Technologies, you can compare the effects of market volatilities on BioAffinity Technologies, and Agilent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of Agilent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and Agilent Technologies.
Diversification Opportunities for BioAffinity Technologies, and Agilent Technologies
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between BioAffinity and Agilent is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and Agilent Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agilent Technologies and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with Agilent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agilent Technologies has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and Agilent Technologies go up and down completely randomly.
Pair Corralation between BioAffinity Technologies, and Agilent Technologies
Given the investment horizon of 90 days bioAffinity Technologies, is expected to under-perform the Agilent Technologies. In addition to that, BioAffinity Technologies, is 1.7 times more volatile than Agilent Technologies. It trades about -0.36 of its total potential returns per unit of risk. Agilent Technologies is currently generating about 0.0 per unit of volatility. If you would invest 13,965 in Agilent Technologies on September 5, 2024 and sell it today you would lose (37.00) from holding Agilent Technologies or give up 0.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
bioAffinity Technologies, vs. Agilent Technologies
Performance |
Timeline |
bioAffinity Technologies, |
Agilent Technologies |
BioAffinity Technologies, and Agilent Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioAffinity Technologies, and Agilent Technologies
The main advantage of trading using opposite BioAffinity Technologies, and Agilent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, Agilent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will offset losses from the drop in Agilent Technologies' long position.BioAffinity Technologies, vs. Intelligent Bio Solutions | BioAffinity Technologies, vs. T2 Biosystms | BioAffinity Technologies, vs. Genetic Technologies | BioAffinity Technologies, vs. Psychemedics |
Agilent Technologies vs. Verve Therapeutics | Agilent Technologies vs. Beam Therapeutics | Agilent Technologies vs. Caribou Biosciences | Agilent Technologies vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
CEOs Directory Screen CEOs from public companies around the world |